A Comparison of Nab-PHP and TCbHP Efficacy in Neoadjuvant Therapy for HER2-positive Early Breast Cancer
Clinical trial NCT04547907 · RECRUITING
Trial details
- NCT number
- NCT04547907
- Sponsor
- Henan Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-18
- Primary completion
- 2024-12-31
- Enrollment
- 688
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.